SI-BONE, Inc.
SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On September 11, 2026, SI-BONE, Inc. (the “Company”) and BIXBY SPE FINANCE 11, LLC (“Landlord”) entered into the Fourth Amendment to Lease (the “Fourth Lease Amendment”) to the Office Lease Agreement dated as of February 2, 2
FRANCIS LAURA (Chief Executive Officer) sold 25,972 indirectly-held shares of SI-BONE, Inc. (SIBN) at $20.12 ($0.52M total) on 2026-08-24 under a Rule 10b5-1 trading plan.
SI-BONE (SIBN) reported that a trust plans to sell 25,972 shares of its common stock under Rule 144. The shares were acquired from restricted stock units that vested starting May 15, 2021. The filing also details recent sales by the trust and Laura Francis, including 10b5-1 plan transactions.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning SIBN (SI-BONE, Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Recent SIBN coverage spans insider activity, corporate actions and earnings.
In the last 30 days, SIBN insiders filed 16 SEC Form 4 transactions — no purchases and 16 sales ($2.8M). The most active reporter was FRANCIS LAURA, Chief Executive Officer, with 8 filings. 44% of those filings were made under pre-arranged Rule 10b5-1 plans.
Recall may modestly pressure the stock; lease extension is minor. Potential short‑term downside if costs exceed expectations.
The insider sale may signal confidence concerns, potentially exerting slight downward pressure on SIBN.
The upcoming share sale could create modest downward pressure on SIBN price.
Insider sell may signal reduced confidence or simply portfolio rebalancing; limited price impact expected.
Routine insider selling with no 10b5-1 plan disclosed; likely limited incremental signal versus broader fundamentals.
AlphAI scores every news story that mentions SIBN with an AI model for sentiment and relevance, and aggregates insider trades from SI-BONE, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On September 11, 2026, SI-BONE, Inc. (the “Company”) and BIXBY SPE FINANCE 11, LLC (“Landlord”) entered into the Fourth Amendment to Lease (the “Fourth Lease Amendment”) to the Office Lease Agreement dated as of February 2, 2
1 min readFRANCIS LAURA (Chief Executive Officer) sold 25,972 indirectly-held shares of SI-BONE, Inc. (SIBN) at $20.12 ($0.52M total) on 2026-08-24 under a Rule 10b5-1 trading plan.
1 min readSI-BONE (SIBN) reported that a trust plans to sell 25,972 shares of its common stock under Rule 144. The shares were acquired from restricted stock units that vested starting May 15, 2021. The filing also details recent sales by the trust and Laura Francis, including 10b5-1 plan transactions.
1 min readFRANCIS LAURA (Chief Executive Officer) sold 55,807 indirectly-held shares of SI-BONE, Inc. (SIBN) at an average of $19.50 ($19.46–$20.02, $1.09M total) across 2 trades over 2026-08-20 to 2026-08-21 under a Rule 10b5-1 trading plan.
1 min readFRANCIS LAURA (Chief Executive Officer) sold 14,956 shares of SI-BONE, Inc. (SIBN) at an average of $18.66 ($18.63–$18.68, $0.28M total) across 5 trades on 2026-08-17.
2 min readSI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Quarter 2026 Financial Highlights (all comparisons are to t
6 min readSi-Bone, Inc. (SIBN) is scheduled to report Q2 2026 earnings on Aug. 3 after market close, with results expected at 4:09 PM ET. The consensus outlook cited for the quarter includes revenue of $55.34 million and EPS of -$0.15 (USD).
1 min readSI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. sibn-20260604 0001459839 false 0001459839 2026-06-04 2026-06-04 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________ FORM 8-K __________________________________________________________
2 min readDavis Timothy E JR sold 3,500 shares of SI-BONE, Inc. (SIBN) at $14.14 on 2026-05-29.
2 min readDavis Timothy E JR sold 3,780 shares of SI-BONE, Inc. (SIBN) at $14.47 on 2026-05-28.
1 min read
